For: | Zhao HJ, Hu YF, Han QJ, Zhang J. Innate and adaptive immune escape mechanisms of hepatitis B virus. World J Gastroenterol 2022; 28(9): 881-896 [PMID: 35317051 DOI: 10.3748/wjg.v28.i9.881] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i9/881.htm |
Number | Citing Articles |
1 |
Bing Yue, Yuxia Gao, Yi Hu, Meixiao Zhan, Yangzhe Wu, Ligong Lu. Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions. Clinical and Translational Medicine 2024; 14(7) doi: 10.1002/ctm2.1731
|
2 |
Jinfang Hao, Hui Wang, Xiufeng Lu, Zimo Li, Xiaoyan Zhang. TLR4 signalling: the key to controlling EV71 replication and inflammatory response. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1393680
|
3 |
Angela Quirino, Nadia Marascio, Francesco Branda, Alessandra Ciccozzi, Chiara Romano, Chiara Locci, Ilenia Azzena, Noemi Pascale, Grazia Pavia, Giovanni Matera, Marco Casu, Daria Sanna, Marta Giovanetti, Giancarlo Ceccarelli, Pierfrancesco Alaimo di Loro, Massimo Ciccozzi, Fabio Scarpa, Antonello Maruotti. Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies. Pathogens 2024; 13(9): 766 doi: 10.3390/pathogens13090766
|
4 |
Mehlayl Tariq, Abu Bakar Shoukat, Sedrah Akbar, Samaia Hameed, Muniba Zainab Naqvi, Ayesha Azher, Muhammad Saad, Muhammad Rizwan, Muhammad Nadeem, Anum Javed, Asad Ali, Shahid Aziz. Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection. SAGE Open Medicine 2022; 10 doi: 10.1177/20503121221105957
|
5 |
Xiaojuan Wu, Wenling Zhao, Qiang Miao, Shiya Shi, Bin Wei, Limei Luo, Bei Cai. CCR2+TREM-1+ monocytes promote natural killer T cell dysfunction contributing towards HBV disease progression. Immunologic Research 2024; doi: 10.1007/s12026-024-09495-4
|
6 |
Wendi Zhang, Haoyu Sun, Rui Sun, Zhexiong Lian, Haiming Wei, Zhigang Tian, Yongyan Chen. HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.993246
|
7 |
Shenghai Shen, Li-Sheng Zhang. The regulation of antiviral innate immunity through non-m6A RNA modifications. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1286820
|
8 |
Yifei Hu, Ailu Yang, Hui Li, Rongrong Zhao, Cuiping Bao, Yating Yu, Yucan Wang, Zixuan Wang, Li Zhuo, Qiuju Han, Zhiyue Zhang, Jian Zhang, Huajun Zhao. Lymph node-targeted STING agonist nanovaccine against chronic HBV infection. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05404-y
|
9 |
Rupchand Sutradhar, D. C. Dalal. Fractional‐order models of hepatitis B virus infection with recycling effects of capsids. Mathematical Methods in the Applied Sciences 2023; 46(14): 15599 doi: 10.1002/mma.9415
|
10 |
Yan Yang, Feilin Ge, Chen Luo, Cai Liao, Junyuan Deng, Yunhao Yang, Yang Chen, Xiao Guo, Zhaofang Bai, Xiaohe Xiao, Chenglin Tang. An Experimental Animal Study: Electroacupuncture Facilitates Antiviral Immunity Against Hepatitis B Virus Through the IFN-γ/JAK/STAT Axis. Journal of Inflammation Research 2024; : 6547 doi: 10.2147/JIR.S477202
|
11 |
Amir Elalouf, Amit Yaniv-Rosenfeld, Hanan Maoz. Immune response against bacterial infection in organ transplant recipients. Transplant Immunology 2024; 86: 102102 doi: 10.1016/j.trim.2024.102102
|
12 |
Hangle Wang, Jun Zhang. The glucose metabolic reprogramming in hepatitis B virus infection and hepatitis B virus associated diseases. Journal of Gastroenterology and Hepatology 2023; 38(11): 1886 doi: 10.1111/jgh.16340
|
13 |
Annika Jasmin Walter, Maarten A. van de Klundert, Stephanie Jung. Many Ways to Communicate—Crosstalk between the HBV-Infected Cell and Its Environment. Pathogens 2022; 12(1): 29 doi: 10.3390/pathogens12010029
|
14 |
Amir Elalouf. Infections after organ transplantation and immune response. Transplant Immunology 2023; 77: 101798 doi: 10.1016/j.trim.2023.101798
|
15 |
Mohamed A Selim, Reda A. Suef, Ebrahim Saied, Mostafa A. Abdel-Maksoud, Saeedah Musaed Almutairi, Mohammed Aufy, Adel A. Mousa, Mohamed T. M. Mansour, Mohamed M. S. Farag. Peripheral NK cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in CHB patients: evading immune surveillance. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1427519
|
16 |
Hui Ma, Qing-Zhu Yan, Jing-Ru Ma, Dong-Fu Li, Jun-Ling Yang. Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies. World Journal of Gastroenterology 2024; 30(10): 1295-1312 doi: 10.3748/wjg.v30.i10.1295
Abstract(351) |
Core Tip(346) |
Full Article(HTML)(1726)
|
Full Article with Cover (PDF)-1506K(110)
|
Full Article (Word)-897K(0)
|
Audio-407K(3)
|
Peer-Review Report-310K(38)
|
Answering Reviewers-316K(38)
|
Full Article (PDF)-1251K(136)
|
Full Article (XML)-349K(39)
|
Times Cited (0)
|
Total Visits (3712)
|
Open
|
17 |
Vasile Mihai Sularea, Jamie A Sugrue, Cliona O’Farrelly. Innate antiviral immunity and immunometabolism in hepatocytes. Current Opinion in Immunology 2023; 80: 102267 doi: 10.1016/j.coi.2022.102267
|
18 |
Ruqing Xu, Yue Wu, Xia Xiang, Xiaoqin Lv, Miao He, Chang Xu, Guoqi Lai, Tingxiu Xiang. Sulforaphane effectively inhibits HBV by altering Treg/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo. Virus Research 2024; 341: 199316 doi: 10.1016/j.virusres.2024.199316
|
19 |
Juliana Echevarria-Lima, Ramona Moles. Monocyte and Macrophage Functions in Oncogenic Viral Infections. Viruses 2024; 16(10): 1612 doi: 10.3390/v16101612
|
20 |
Jia-Rui Zheng, Zi-Long Wang, Bo Feng. Hepatitis B functional cure and immune response. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1075916
|
21 |
Poornima Ramburrun, Mershen Govender, Yahya E. Choonara. Nanomedicines for the Prevention and Treatment of Infectious Diseases. AAPS Advances in the Pharmaceutical Sciences Series 2023; 56: 349 doi: 10.1007/978-3-031-39020-3_12
|